De Angelis, Floriana
Plantone, Domenico
Chataway, Jeremy
Article History
First Online: 3 July 2018
Compliance with Ethical Standards
:
: No funding was received for the preparation of this article.
: Floriana De Angelis and Domenico Plantone have no conflicts of interest directly relevant to the content of this article. Jeremy Chataway has received support from the Efficacy and Mechanism Evaluation Programme and Health Technology Assessment Programme (National Institute for Health Research), UK Multiple Sclerosis Society and National Multiple Sclerosis Society. In the last 3 years, he has been a local principal investigator for trials in multiple sclerosis funded by Receptos, Novartis and Biogen Idec, and has received an investigator grant from Novartis outside this work. He has taken part in advisory boards/consultancies for Roche, Merck, MedDay, Biogen and Apitope.